MDS Pharma Services Adopts DataLabs Electronic Data Capture System
06 Avril 2006 - 3:00PM
PR Newswire (US)
New system provides greater efficiency and flexibility in managing
patient data and strengthens Phase IIb-IV offering KING OF PRUSSIA,
PA, April 6 /PRNewswire-FirstCall/ -- MDS Pharma Services, a
leading provider of innovative drug discovery and development
solutions, has adopted DataLabs Clinical Electronic Data Capture
(EDC) system for increased efficiency and flexibility in managing
patient data from clinical trials in geographically diverse sites.
"The adoption of this new system reflects our commitment to
strengthen our Global Clinical Development line of business," said
MDS Pharma Services President, Gilbert Godin. "This technology
enhances our ability to meet growing client demand for our Phase
IIb-IV clinical trial management services and sharpens MDS Pharma
Service's competitive positioning in this fast growing market." The
DataLabs Clinical electronic data management system unifies the
functionality of paper data entry with the flexibility of EDC into
one easy to use, web-based electronic data management platform. The
system allows MDS Pharma Services to design a clinical study once,
collect data either through paper data entry or EDC, and clean and
manage the data with the same system, using virtually the same
process. "DataLabs is pleased to add MDS Pharma Services to our
Contract Research Organization (CRO) Partners Program," said
DataLabs President, Jim Langford. "DataLabs has become the leading
software company for the CRO industry by providing significant
value in both our software and in our business model." About MDS
Pharma Services MDS Pharma Services offers a full spectrum of
resources to meet the drug discovery and development needs of the
pharmaceutical and biotechnology industries. With numerous
facilities strategically located around the world, the company
applies advanced scientific and technological expertise to each
stage of the drug discovery and development process - Early Stage:
lead optimization, pre-IND research, pharmaceutical and
biopharmaceutical development, early clinical research
(bioequivalence, phases I-IIa) and bioanalysis; and Late Stage:
global clinical development (phases IIb-IV) and central lab. For
more information, visit MDS Pharma Services' Web site at
http://www.mdsps.com/. MDS Pharma Services is an integral part of
MDS Inc. (TSX: MDS; NYSE: MDZ). MDS Inc. has more than 8,800 highly
skilled people in 27 countries. We provide a diverse range of
superior products and services to increase our customers' speed,
precision and productivity in the drug development and disease
diagnosis processes. We are a global, values-driven life sciences
company, recognized for our reliability and collaborative
relationships as we help create better outcomes in the treatment of
disease. Find out more at http://www.mdsinc.com/ or by calling
1-800-MDS-7222, 24 hours a day. About DataLabs DataLabs is an
innovative developer of Web-based applications for clinical
development that helps the CRO and biopharmaceutical industries
accelerate clinical trials with proven software for electronic
clinical data management, electronic clinical collaboration, site
management, and web based eLearning software. Based on Microsoft
platform technology, XML Web services and CDISC ODM standards, the
DataLabs Clinical product suite adapts to established operating
procedures and integrates easily with existing technology systems.
As a result, DataLabs Clinical customers enjoy a low total cost of
ownership and high return on investment. Major pharmaceutical
companies, government entities, healthcare organizations and
contract research organizations (CROs) are currently realizing time
and cost savings using DataLabs Clinical. DataLabs, a Microsoft
Certified Partner, is based in Irvine, Calif. with East Coast
offices in Pennsylvania. Additional information about DataLabs is
available at http://www.datalabs.com/. DATASOURCE: MDS Pharma
Services CONTACT: For Investors, Sharon Mathers, (416) 675-6777,
ext. 2695, ; For Media, Charlene McGrady, (610) 239-7900, ext. 231,
Copyright